INTERNATIONAL PATENT: BATTELLE MEMORIAL INSTITUTE FILES APPLICATION FOR "ANTI-GHRELIN BUTYRYLCHOLINESTERASE ENZYME THERAPEUTIC"

GENEVA, March 31 -- BATTELLE MEMORIAL INSTITUTE (505 King AvenueColumbus, Ohio 43201) filed a patent application (PCT/US2025/046450) for "ANTI-GHRELIN BUTYRYLCHOLINESTERASE ENZYME THERAPEUTIC" on Sep 15, 2025. With publication no. WO/2026/064250, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): NEAL, Matthew (c/o Battelle Memorial Institute505 King AvenueColumbus, Ohio 43201)

Abstract: Compositions and methods are provided for inactivating ghrelin in mammalian cells by administration of a polynucleotide encoding a butyryl...